Targeting prostate cancer with compounds possessing dual activity as androgen receptor antagonists and HDAC6 inhibitors - Concepedia

Concepedia

Publication | Open Access

Targeting prostate cancer with compounds possessing dual activity as androgen receptor antagonists and HDAC6 inhibitors

DOI Full Paper Access

17

Citations

21

References

2016

Year

Pradeep S. Jadhavar, Sreekanth A. Ramachandran, Eduardo Riquelme, Ashu Gupta, Kevin P. Quinn, Devleena Shivakumar, Soumya S. Ray, Dnyaneshwar Zende, Anjan K. Nayak, Sandeep K. Miglani,

Bioorganic & Medicinal Chemistry Letters

UrologyDrug TargetingHdac6 InhibitorsMedicineDual ActivityPharmacotherapyAnti-cancer AgentProstatic DiseasePharmacologyDrug Discovery

References

	Year	Citations

Page 1

Page 1